Category: Publications

Synthetic biologist Joshua Leonard and his team have developed a technology for engineering human cells as therapies that become activated only in diseased tissues.

Northwestern synthetic biology researchers, working with partners at Harvard Medical School, have for the first time synthesized protein-generating cell structures called ribosomes in a test tube.